InsiderClue
Insiders · Profile

HASTINGS DAVID C

Chief Financial Officer at Arbutus Biopharma · Director at SCYNEXIS · Chief Financial Officer at Incyte. Filing since 20 Nov 2008. CIK 0001237401

ABUS Arbutus Biopharma Corp Chief Financial Officer · 2 trades SCYX SCYNEXIS INC Director · 2 trades INCY Incyte Chief Financial Officer · 10 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ABUS Arbutus Biopharma Corp
4 Feb 2025
Chief Financial Officer
Sold on a plan
22,183
$72.83K
12.2%
ABUS Arbutus Biopharma Corp
2 Feb 2024
Chief Financial Officer
Sold on a plan
9,593
$22.18K
5.0%
SCYX SCYNEXIS INC
8 Mar 2018
Director
Bought
11,834
$20.00K
59.2%
SCYX SCYNEXIS INC
21 Jun 2017
Director
Bought
20,000
$35.00K
opened
INCY Incyte
5 Jun 2014
Chief Financial Officer
Sold, plan not stated
123,966
$6.55M
93.6%
INCY Incyte
4 Jun 2014
Chief Financial Officer
Sold, plan not stated
76,034
$4.00M
89.9%
INCY Incyte
18 Feb 2014
Chief Financial Officer
Sold, plan not stated
32,001
$2.10M
79.0%
INCY Incyte
14 Feb 2014
Chief Financial Officer
Sold, plan not stated
40,000
$2.59M
82.5%
INCY Incyte
13 Feb 2014
Chief Financial Officer
Sold, plan not stated
202,999
$13.42M
96.0%
INCY Incyte
6 Sep 2013
Chief Financial Officer
Sold, plan not stated
100,000
$3.52M
92.2%
INCY Incyte
15 Feb 2013
Chief Financial Officer
Sold, plan not stated
100,000
$2.25M
92.2%
INCY Incyte
9 Jun 2011
Chief Financial Officer
Sold, plan not stated
100,000
$1.77M
92.2%
INCY Incyte
1 Jul 2010
Chief Financial Officer
Bought
2,000
$20.48K
30.8%
INCY Incyte
20 Nov 2008
Chief Financial Officer
Bought
4,000
$9.44K
160%
14 decisions on file.